Literature DB >> 26896356

Risk calculators are useful but....

Xiaofei Wang1, Mark F Berry2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26896356      PMCID： PMC4766856          DOI： 10.1016/j.jtcvs.2015.09.058

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  9 in total

Review 1.  Sublobar resection: a movement from the Lung Cancer Study Group.

Authors:  Justin D Blasberg; Harvey I Pass; Jessica S Donington
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

2.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

3.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

4.  Decision curve analysis: a novel method for evaluating prediction models.

Authors:  Andrew J Vickers; Elena B Elkin
Journal:  Med Decis Making       Date:  2006 Nov-Dec       Impact factor: 2.583

5.  Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.

Authors:  Nasser K Altorki; Rowena Yip; Takaomi Hanaoka; Thomas Bauer; Ralph Aye; Leslie Kohman; Barry Sheppard; Richard Thurer; Shahriyour Andaz; Michael Smith; William Mayfield; Fred Grannis; Robert Korst; Harvey Pass; Michaela Straznicka; Raja Flores; Claudia I Henschke
Journal:  J Thorac Cardiovasc Surg       Date:  2013-11-23       Impact factor: 5.209

6.  Predictors of prolonged length of stay after lobectomy for lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk-adjustment model.

Authors:  Cameron D Wright; Henning A Gaissert; Joshua D Grab; Sean M O'Brien; Eric D Peterson; Mark S Allen
Journal:  Ann Thorac Surg       Date:  2008-06       Impact factor: 4.330

7.  The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non-small cell lung cancer.

Authors:  Pamela Samson; Clifford G Robinson; Jeffrey Bradley; Audrey Lee; Stephen Broderick; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Varun Puri; Bryan F Meyers; Traves Crabtree
Journal:  J Thorac Cardiovasc Surg       Date:  2015-08-24       Impact factor: 5.209

8.  A framework for evaluating markers used to select patient treatment.

Authors:  Holly Janes; Margaret S Pepe; Ying Huang
Journal:  Med Decis Making       Date:  2013-06-27       Impact factor: 2.583

9.  Using relative utility curves to evaluate risk prediction.

Authors:  Stuart G Baker; Nancy R Cook; Andrew Vickers; Barnett S Kramer
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2009-10-01       Impact factor: 2.483
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.